Direkt zum Inhalt
Merck

JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against

Oncotarget (2017-11-22)
Huogang Wang, Bo Hong, Xuemin Li, Ke Deng, Hong Li, Vivian Wai Yan Lui, Wenchu Lin
ZUSAMMENFASSUNG

Small cell lung cancer (SCLC) is a clinically aggressive cancer with very poor prognosis. Amplification of

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
MISSION® esiRNA, targeting human MYCN (1)